First study of genital HPV infection among women living with HIV recruited from May to September 2018 in Eastern Algeria

Int J STD AIDS. 2023 Oct;34(12):890-896. doi: 10.1177/09564624231179274. Epub 2023 Jun 28.

Abstract

Background: Genital HPV infection is recognized worldwide as one of the most common, if not the most common, sexually transmitted infection. Several studies have shown a higher prevalence of HPV infection in women living with HIV (WLWH). We aimed to determine the prevalence of HPV, the circulating genotypes, and its association with risk factors among Algerian WLHIV.

Methods: Cervical specimens were collected from 100 WLHIV. The detection of HPV infection was performed by Roche Linear Array test.

Results: The overall prevalence of HPV infection was determined at 32%, all including high risk HPV (HR-HPV). We found a great diversity of HR-HPV genotypes, the most common individually were HPV52, HPV16, HPV18 and HPV58, The highest prevalence was found in groups of genotype 52, 25%. HPV16 and 18 were less common (16%). Cervical cytology was abnormal in 66% (81.3% in the HPV + population), with a predominance of inflammatory lesions (75% HPV +), The most important determining risk factor for HPV infection in this series was a low CD4 T cell count <200/mm3 found in 72% of the HPV positive participants.

Conclusion: Our study is an initial database, to be completed by a multicenter study to determine the most frequent genotypes in Algerian WLHIV, in order to discuss the introduction of the vaccine against HPV in Algeria, especially among WLHIV.

Keywords: AIDS; ART (antiretroviral therapy); HPV (Human papillomavirus); genital warts; sexual intercourse; viral disease.

Publication types

  • Multicenter Study

MeSH terms

  • Algeria / epidemiology
  • Alphapapillomavirus
  • Cervix Uteri / pathology
  • Female
  • Genotype
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • Human Papillomavirus Viruses
  • Humans
  • Papillomaviridae / genetics
  • Papillomavirus Infections*
  • Prevalence
  • Uterine Cervical Dysplasia* / epidemiology
  • Uterine Cervical Neoplasms* / epidemiology

Supplementary concepts

  • human papillomavirus 52
  • human papillomavirus 58